1. Home
  2. FRAF vs ALLO Comparison

FRAF vs ALLO Comparison

Compare FRAF & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Financial Services Corporation

FRAF

Franklin Financial Services Corporation

HOLD

Current Price

$49.78

Market Cap

214.2M

Sector

Finance

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.66

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRAF
ALLO
Founded
1906
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
214.2M
252.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
FRAF
ALLO
Price
$49.78
$1.66
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$8.27
AVG Volume (30 Days)
59.0K
6.4M
Earning Date
01-27-2026
03-12-2026
Dividend Yield
2.67%
N/A
EPS Growth
88.84
N/A
EPS
4.74
N/A
Revenue
$85,923,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.47
N/A
Revenue Growth
24.15
N/A
52 Week Low
$32.39
$0.86
52 Week High
$59.95
$3.78

Technical Indicators

Market Signals
Indicator
FRAF
ALLO
Relative Strength Index (RSI) 48.12 50.95
Support Level $48.32 $1.56
Resistance Level $50.25 $1.84
Average True Range (ATR) 1.93 0.15
MACD 0.04 -0.02
Stochastic Oscillator 48.71 36.89

Price Performance

Historical Comparison
FRAF
ALLO

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: